LP
TMDX icon

Longaeva Partners’s Transmedics TMDX Stock Holding History

Longaeva Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69,057
Closed -$6.86M – 405
2026
Q1 		$6.86M Buy
+69,057
New +$9.01M 0.25% 91

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Longaeva Partners's TMDX Position: Q2 2026 in Review

Longaeva Partners sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 69,057 shares — an estimated $6.86M sold.

Longaeva Partners first reported a position in TMDX in Q1 2026 and held it in 1 quarter. The position peaked at $6.86M in Q1 2026. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Longaeva Partners reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Longaeva Partners sold 69,057 Transmedics shares in Q2 2026, an estimated $6.86M.
  • Longaeva Partners first reported a position in Transmedics in Q1 2026 and held it in 1 quarter.
  • Longaeva Partners's Transmedics position peaked at $6.86M in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.